Examples included prostate-specific membrane antigen (PSMA), androgen-sensitive human prostate adenocarcinoma cells (LNCaP), prostatic acid phosphatase (PAP), and prostate stem cell antigen (PSCA). This evidence concerns the gene FOLH1 and prostate adenocarcinoma.